z-logo
open-access-imgOpen Access
Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
Author(s) -
Sudhakar Agnihothram,
Robin Gopal,
Boyd L. Yount,
Eric Donaldson,
Vineet D. Menachery,
Rachel L. Graham,
Trevor Scobey,
Lisa E. Gralinski,
Mark R. Denison,
Maria Zambon,
Ralph S. Baric
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit609
Subject(s) - virology , middle east respiratory syndrome coronavirus , coronavirus , epitope , biology , serology , middle east respiratory syndrome , antigen , betacoronavirus , coronaviridae , virus , plaque reduction neutralization test , immunodominance , neutralization , antibody , immunology , disease , medicine , infectious disease (medical specialty) , covid-19 , pathology
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing severe acute respiratory disease and pneumonia, with 44% mortality among 136 cases to date. Design of vaccines to limit the virus spread or diagnostic tests to track newly emerging strains requires knowledge of antigenic and serologic relationships between MERS-CoV and other CoVs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom